S 4152 · 117th Congress
A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
This bill extends a federal program that helps speed up the development of new medicines and medical treatments. The program, called the Critical Path Public-Private Partnerships, brings together the FDA (the government agency that approves drugs), pharmaceutical companies, and medical researchers to work on shared…
- Sponsor
- Kelly, Mark (D-AZ)
- Introduced
- 2022-05-05
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Digging through Congress... 🔍